Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
University of Southern California
National Institutes of Health Clinical Center (CC)
Elevation Oncology
Valerio Therapeutics
Tango Therapeutics, Inc.
Pfizer
Haihe Biopharma Co., Ltd.
OHSU Knight Cancer Institute
Leap Therapeutics, Inc.
Centre Hospitalier Universitaire de Besancon
pharmaand GmbH
Genmab
Nuvation Bio Inc.
Eastern Cooperative Oncology Group
West Virginia University
Duke University
National Institutes of Health Clinical Center (CC)
MacroGenics
Advanced Accelerator Applications
Tetra Bio-Pharma
InSightec
Scripps Translational Science Institute
University of Wisconsin, Madison
M.D. Anderson Cancer Center
CureOne
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Pittsburgh
University Health Network, Toronto
Norwegian University of Science and Technology
Otsuka Novel Products GmbH
Virginia Commonwealth University
Merck Sharp & Dohme LLC
Mirati Therapeutics Inc.
Pfizer
Calando Pharmaceuticals
Emory University